Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Credit

<ul><li>Colgate-Palmolive’s focus on productivity, pricing, premiumization, and innovation allowed it to deliver a decent financial performance in 2021 despite a challenging operating environment.</li><li>The company is focused on delivering profitable, sustainable, and consistent growth in price and volume categories in developed and emerging markets and growth in every division and category.</li><li>The management’s investments in R&D and marketing are meant to accelerate the introduction of premium innovation to drive profitability and mix.</li></ul>

Colgate-Palmolive’s focus on productivity, pricing, premiumization, and innovation allowed it to deliver a decent financial performance in 2021 despite a challenging operating environment.The company is focused on delivering profitable, sustainable, and consistent growth in price and volume categories in developed and emerging markets and growth in every division and category.The management’s investments in R&D and marketing are meant to accelerate the introduction of premium innovation to drive profitability and mix.

Colgate-Palmolive: Detailed Credit Analysis & Financial Strength Evaluation Report

Equity Capital Markets

Colgate Palmolive Co / Equity Capital Markets

<ul><li>Colgate-Palmolive delivered a mixed quarterly result to end 2021 but its overall performance was not too bad.</li><li>The management’s focus on productivity, pricing, premiumization, and innovation allowed the company to navigate through a challenging operating environment.</li><li>The management’s investments in R&D and marketing are meant to accelerate the introduction of premium innovation to drive profitability and mix.</li></ul>

Colgate-Palmolive delivered a mixed quarterly result to end 2021 but its overall performance was not too bad.The management’s focus on productivity, pricing, premiumization, and innovation allowed the company to navigate through a challenging operating environment.The management’s investments in R&D and marketing are meant to accelerate the introduction of premium innovation to drive profitability and mix.

Colgate-Palmolive: Financial & Price Forecasts

<ul><li>Despite the volatility that Colgate-Palmolive has experienced in their business lines, the company’s stock price has been more or less rangebound.</li><li>Colgate-Palmolive had to resort to increased pricing to combat inflation but its volumes grew as well, both, sequentially and on a two-year basis.</li><li>Oral Care organic sales increased by the mid-single digits in Q3 compared to the previous quarter and are up by the high-single digits year-to-date.</li></ul>

Despite the volatility that Colgate-Palmolive has experienced in their business lines, the company’s stock price has been more or less rangebound.Colgate-Palmolive had to resort to increased pricing to combat inflation but its volumes grew as well, both, sequentially and on a two-year basis.Oral Care organic sales increased by the mid-single digits in Q3 compared to the previous quarter and are up by the high-single digits year-to-date.

Colgate-Palmolive: A Stable Consumer Goods Play (12/2021)

Value Investing

Vladimir Dimitrov, CFA

Equity Bottom-Up

<ul>
<li>Reckitt Benckiser has been one of the worst performers in the large cap household &amp; personal products space.</li>
<li>Past mistakes in strategic capital allocation are still lingering over the business, while debt levels will likely require more divestments.</li>
<li>The business, however, is in a good position to regain shareholders' trust and its leading position in the industry.</li>
</ul>


Reckitt Benckiser has been one of the worst performers in the large cap household &amp; personal products space.
Past mistakes in strategic capital allocation are still lingering over the business, while debt levels will likely require more divestments.
The business, however, is in a good position to regain shareholders' trust and its leading position in the industry.


Reckitt Benckiser - Still Paying For Past Mistakes

<ul><li>Colgate-Palmolive delivered a decent result, surpassing revenue expectations of Wall Street as a result of continued business momentum.</li><li>The company witnessed a 5% organic growth which was driven by a combination of price increases as well as volume growth.</li><li>However, despite the price increase, the management has failed to prevent a margin contraction at the gross margin level.</li></ul>

Colgate-Palmolive delivered a decent result, surpassing revenue expectations of Wall Street as a result of continued business momentum.The company witnessed a 5% organic growth which was driven by a combination of price increases as well as volume growth.However, despite the price increase, the management has failed to prevent a margin contraction at the gross margin level.

Colgate-Palmolive Company - Investment Thesis

United States

Colgate-Palmolive Company is a consumer products company that markets its products throughout the world.  The Company's products include toothpaste, toothbrushes, shampoos, deodorants, bar and liquid soaps, dishwashing liquid, and laundry products, as well as pet nutrition products for cats and dogs.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Colgate Palmolive Co (CL US)

Colgate-Palmolive: Detailed Credit Analysis & Financial Strength Evaluation Report

Colgate-Palmolive’s focus on productivity, pricing, premiumization, and innovation allowed it to deliver a decent financial performance in 2021...

Baptista Research

Colgate-Palmolive: Financial & Price Forecasts

Colgate-Palmolive delivered a mixed quarterly result to end 2021 but its overall performance was not too bad. The management’s focus on...

Baptista Research

Colgate-Palmolive: A Stable Consumer Goods Play (12/2021)

Despite the volatility that Colgate-Palmolive has experienced in their business lines, the company’s stock price has been more or less...

Baptista Research

Reckitt Benckiser - Still Paying For Past Mistakes

Reckitt Benckiser has been one of the worst performers in the large cap household & personal products space. Past mistakes in strategic...

Vladimir Dimitrov, CFA

Colgate-Palmolive Company - Investment Thesis

Colgate-Palmolive delivered a decent result, surpassing revenue expectations of Wall Street as a result of continued business momentum. The...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)